InvestorsHub Logo
icon url

DarthYoda

03/01/23 6:01 PM

#79849 RE: GE_Jim #79846

IMO, CV writes off very little inventory compared to how much they don't sell. If there's not a big write down in the next report, I think CV is keeping raw material around longer than they are supposed to. Who's checking though right? Not the FDA. The inventory keeps those "assets" looking fluffy on the balance sheet...

Inventory
Inventory as of September 30, 2022 and December 31, 2021 was comprised of the following (in thousands):
September 30, 2022 December 31, 2021
Raw materials $3,698 $4,023
Work in process 1,221 1,286
Finished goods 2,307 3,315
$7,226 $8,624

The Company recorded inventory write-downs of $0.1 million and $0.3 million for the three and nine months ended September 30, 2022, respectively. Inventory write-offs for the three and nine months ended September 30, 2021 were $0.1 million and $0.2 million, respectively.


https://www.otcmarkets.com/filing/html?id=16199697&guid=1D4-karWJBqmB3h